Replies to post #3493 on Pfizer Inc (PFE)

[DewDiligence]

PFE guidance—>$33.5B_2021_COVID_sales—(prior_$26B)—2021_EPS†_$3.95-4.05—(prior_$3.55-3.65):

2Q21 PR:
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-second-quarter-2021-results

2Q21 CC slides:
https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf

The $33.5B forecast for 2021 COVID-vaccine sales is based on signed contracts to deliver 2.1B doses.

PFE and BNTX split global COVID-vaccine profits 50/50.

†Non-GAAP.